Literature DB >> 17467328

Intracellular pH regulation in oral squamous cell carcinoma is mediated by increased V-ATPase activity via over-expression of the ATP6V1C1 gene.

Eva María Otero-Rey1, Manuel Somoza-Martín, Francisco Barros-Angueira, Abel García-García.   

Abstract

Oral squamous cell carcinomas represent more than 90% of all head and neck cancers, and comprise about 4% of all malignancies in western countries. Tumor cell mobility related to increasing intracellular pH results in impaired proliferation and metastasis, suggesting an important role of pH regulation in solid cancer tumorigenesis. The mechanism of physiological pH regulation has been shown to be activated in several solid tumors through constitutive activation of the ATPase complex. How cells regulate this mechanism has not been elucidated in human cancer in detail. The present study, using expression profiling by cDNA array analysis of oral squamous cell carcinoma cells, identified the V-ATPase system as a significant regulatory mechanism. ATP6V1C1 was the most strongly over-expressed gene in oral squamous cell carcinoma at the mRNA level compared to other genes of the V-ATPase complex. These findings provide evidence that intracellular pH regulation is mainly controlled by expression of a single gene, ATP6V1C1, notwithstanding the possible action of other secondary regulatory factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467328     DOI: 10.1016/j.oraloncology.2007.02.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  19 in total

Review 1.  Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades.

Authors:  Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

2.  Regulation of Notch signaling and endocytosis by the Lgl neoplastic tumor suppressor.

Authors:  Marta Portela; Linda M Parsons; Nicola A Grzeschik; Helena E Richardson
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Estimating the rotation rate in the vacuolar proton-ATPase in native yeast vacuolar membranes.

Authors:  Csilla Ferencz; Pál Petrovszki; Zoltán Kóta; Elfrieda Fodor-Ayaydin; Lajos Haracska; Attila Bóta; Zoltán Varga; András Dér; Derek Marsh; Tibor Páli
Journal:  Eur Biophys J       Date:  2012-11-16       Impact factor: 1.733

4.  Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells.

Authors:  Christina M McGuire; Michael P Collins; GeHong Sun-Wada; Yoh Wada; Michael Forgac
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

5.  Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.

Authors:  Dong Liang; Larissa Meyer; David W Chang; Jie Lin; Xia Pu; Yuanqing Ye; Jian Gu; Xifeng Wu; Karen Lu
Journal:  Cancer Res       Date:  2010-11-30       Impact factor: 12.701

6.  Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer.

Authors:  Kirsten Lindner; Christiane Borchardt; Maren Schöpp; Anja Bürgers; Christian Stock; Damian J Hussey; Jörg Haier; Richard Hummel
Journal:  J Exp Clin Cancer Res       Date:  2014-09-01

7.  Decreased expression of LASS2 is associated with worse prognosis in meningiomas.

Authors:  Rong-Hu Ke; Yin Wang; Yin Mao; Jun Zhang; Ji Xiong
Journal:  J Neurooncol       Date:  2014-04-17       Impact factor: 4.130

Review 8.  The Function of V-ATPases in Cancer.

Authors:  Laura Stransky; Kristina Cotter; Michael Forgac
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

9.  The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma.

Authors:  Toshiya Morimura; Keiko Fujita; Masumi Akita; Masabumi Nagashima; Akira Satomi
Journal:  Pediatr Surg Int       Date:  2008-10       Impact factor: 1.827

10.  Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion.

Authors:  Vera Michel; Yamhilette Licon-Munoz; Kristina Trujillo; Marco Bisoffi; Karlett J Parra
Journal:  Int J Cancer       Date:  2012-09-21       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.